Clinical and molecular dissection of CAR T cell resistance in pancreatic cancer
M. Ángela Aznar(University of Pennsylvania), Mark H. O’Hara(University of Pennsylvania), Shunichiro Kuramitsu(University of Pennsylvania), Gabriela Plesa(University of Pennsylvania), Greg Donahue(University of Pennsylvania), Julie S. Barber-Rotenberg(University of Pennsylvania), Shelley L. Berger(University of Pennsylvania), Sangya Agarwal(Amgen (United States)), Vanessa Gonzalez(University of Pennsylvania), Zhen Zhang(Fuzhou University), Joseph A. Fraietta(University of Pennsylvania), János L. Tanyi(Penn Center for AIDS Research), Andrew J. Rech(Parker Institute for Cancer Immunotherapy), Charly R. Good(University of Pennsylvania), Karl M. Glastad(Georgia Institute of Technology), Wei-Ting Hwang(University of Pennsylvania), Emily Dowd(University of Pennsylvania), Katherine A. Alexander(University of Illinois Chicago), G. Nadolski(Hospital of the University of Pennsylvania), Wesley V. Wilson(University of Pennsylvania), Donna Gonzales(University of Pennsylvania), Drew A. Torigian(University of Pennsylvania), Julie K. Jadlowsky(University of Pennsylvania), Austin K. Rennels(University of Pennsylvania), Hua Huang(Shaoxing University), Elizabeth O. Hexner(University of Pennsylvania), Regina M. Young(Parker Institute for Cancer Immunotherapy), Andrew R. Haas(University of Pennsylvania), Carl H. June(University of Pennsylvania), Donald L. Siegel(University of Pennsylvania), Andrea Brennan(University of Pennsylvania)
Cited by 12
Related Papers
CAR T Cells Produced in vivo to Treat Cardiac Injury
|HAL (Le Centre pour la Communication Scientifique Directe)|2023|940
Targeting cardiac fibrosis with engineered T cells
|Nature|2019|799
TCF-1-Centered Transcriptional Network Drives an Effector versus Exhausted CD8 T Cell-Fate Decision
|Immunity|2019|703
Transcriptional activation via sequential histone H2B ubiquitylation and deubiquitylation, mediated by SAGA-associated Ubp8
|Genes & Development|2003|699
An introduction to chimeric antigen receptor (CAR) T‐cell immunotherapy for human cancer
|American Journal of Hematology|2019|608